In this study, we demonstrate that glycosylation of CD82 at Asn157 is fundamental to ensure CD82-mediated inhibition of ovarian cancer cell migration and metastasis both in vitro and in vivo. The gene discussed is CD82; the disease is ovarian carcinoma.